At the Central Drugs Standard Control Organisation in New Delhi, a new public relation office will be operative soon.

It would serve as a ‘single window’ for disposal of grievances of stakeholders as well as provide information to innovators regarding regulatory requirements for commercialisation of their products.

The new facility would be headed by Assistant Drugs Controller (India) Sunil Kulshreshtra, Drug Inspector Sanjay Aggarwal and Assistant Drug Inspector Vibha Sharma.

They would be reporting to the Drugs Controller General of India (DCGI) S. Eswara Reddy. Mr. Reddy had spoken on the plan to set up a dedicated cell for supporting and providing information pertaining to the regulations to start-ups in the pharma sector, at the BioAsia 2018 held in Hyderabad recently. 

The public relation office would provide clarifications pertaining to Drugs & Cosmetics Act-1940 and other rules. It would guide and assist the investors in various phases of the business lifecycle. 

Big firms or start-ups working on innovative products or solutions can approach the office at any stage for any purpose.

It would give information on the regulatory framework that they need to comply with for market authorisation or commercialisation of their products.